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Vitamin D (Vit D) deficiency is one of the major nutritional deficiencies in children. Obesity has inverse 
association with vitamin D levels. The aim of this study was to determine the differences in response to 
conventional treatment for Vit D deficiency and insufficiency in obese and normal weight children 
and adolescents. 
Materials and Methods: This nested case control study was conducted in 69 obese children and 133 
normal weight matched control suffering from Vit D insufficiency or deficiency. Vit D deficiency was 
defined as serum 25(OH) D3 <10 ng/mL and Vit D insufficiency was defined as 11< 25(OH) D3 <30 
ng/mL. Conventional treatment with 300,000-600,000 IU of vitamin D3 was administered 
intramuscularly over one day for both groups. The participants were followed up after three month. 25 
(OH) D3 was measured at baseline and after the follow up period. Data were analyzed using SPSS 
version 22.0. 
Results: At baseline, mean Vit D level was 13.5 ng/mL in obese and 14.5 ng/mL in normal weight 
children (P>0.05). After follow up, mean Vit D level became 29.6 ng/mL in obese and 33 ng/mL in 
normal weight children (P<0.05). 39.8% of normal weight group still had Vit D insufficiency, while 
50.7% of obese group had Vit D insufficiency or deficiency and the difference was borderline 
significant  (P= 0.064).  
Conclusion 
Therapeutic response in obese children was less than normal weight children. It seems that treatment 
with higher doses of Vit D or longer period is necessary in obese children of the present study.  
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1- INTRODUCTION 
    Vitamin D (Vit D) deficiency is one of 
the most important nutritional issues in 
children (1). Although this problem has 
been greatly solved in the developed 
countries, rickets is still an intractable 
problem in the developing countries (2). 
The prevalence of Vit D deficiency in the 
world is much higher than that of rickets; 
for example, one out of each seven 
adolescents has Vit D deficiency in the 
USA (3). In Turkey that has growing 
prevalence of obesity, the prevalence of 
hypovitaminose D has been reported as 
65% including 12% Vit D deficiency and 
53% Vit D insufficiency (4). In a study 
conducted on the age range of 20-64 years 
in Tehran- Iran, the severe, moderate, and 
mild Vit D deficiency were estimated as 
9.5%, 57.6% and 14.2%, respectively (5). 
Vit D role is not limited to osteogenesis. 
Since Vit D receptors are extensively 
distributed in different tissues such as bone 
and adipose tissue, Vit D deficiency leaves 
severe outcomes on bone and non-bone 
tissues (6). Vit D plays an important role 
in the metabolism of bones, adipogenesis 
and prevention of diseases such as 
osteoporosis, cancer, heart failure, diabetes 
mellitus and immune diseases (7-9). Some 
studies even indicated that Vit D 
deficiency is associated with hypertension, 
psychiatric illnesses such as schizophrenia 
and depression, sudden death, and death 
following heart failure (10-12). Also, there 
is an association between Vit D deficiency 
and pulmonary dysfunction, wheezing, and 
pneumonia (13).  
On the other hand, a specific relationship 
also exists between children’s body weight 
and Vit D level. Different studies showed a 
reverse relationship between the obesity 
and the level of 25-hydroxy vitamin D [25 
OH (D3)] (14-17). Obesity is considered 
as an epidemic problem in the USA. About 
32% of children and adolescents, and 66% 
of young adults are obese (18). It is 
reported that the prevalence of obesity has 
increased significantly within recent two 
or three decades and is about 40% in some 
communities. Hypertension, dyslipidemia, 
insulin resistance, fatty liver disease and 
psychosocial disorders are some impacts 
of obesity on health (19). Considering the 
importance of Vit D in musculoskeletal 
development and fat mass in children, and 
its common deficiency all around the 
world, the aim of the present study was to 
determine the differences in response to 
conventional treatment for Vit D 
deficiency and insufficiency in obese and 
normal weight children and adolescents in 
a nested case control design. 
2- MATERIALS AND METHODS 
2-1. Study design and population 
     This nested case control study was 
conducted in 69 obese and 138 normal 
weight children and adolescents (4-14 
years old) with hypovitaminose D, referred 
for treatment to the Endocrine clinic of 
Children Hospital in Qazvin city, Iran, 
during spring 2013.  
2-2. Methods 
The normal weight group was matched for 
age and gender with obese group. Obesity 
was defined as body mass index (BMI) 
higher than 95th percentile for age and 
gender while normal weight was defined 
as BMI between 5th and 85th percentile 
for age and gender (20). Vit D deficiency 
was defined as 25 (OH) D3 <10 ng/mL 
and 10<25 (OH) D3<29 ng/mL was 
considered as Vit D insufficiency. 
Conventional treatment (stoss therapy) 
with 300,000-600,000 IU of vitamin D3 
was administered intramuscularly as 1-2 
doses over one day for both groups (21). 
The participants were followed up after 
three months. The 25 (OH) D3 level was 
evaluated in the participants after the 
follow up period and the results were 
compared between the groups.  
2-3. Measuring tools  
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Age was calculated in days, months and 
years, based on the birthday. The standing 
height was measured with a wall mounted 
stadiometer seca nearest 1 mm, without 
shoes. The weight was also measured 
using Seca scale (Vogel and Halke, 
Hamburg, Germany), nearest 100 grams. 
The BMI was calculated as weight in 
kilograms per height in squared meters.  
2-4. Laboratory measurements 
Thyroid stimulating hormone (TSH) and 
Thyroxine (T4) level were measured to 
exclude hypothyroidism. Alkaline 
phosphatase (ALP), phosphorus (P), 
calcium (Ca), parathyroid hormone (PTH), 
and 25 (OH) D3 were measured in a single 
laboratory. TSH was measured using 
Electrochemiluminescene (ECL) (Roche, 
Germany). Intra and inter assay 
coefficients of variation (CVs) were ≤ 8.6 
and ≤8.7, respectively. A Hitachi 917 
autoanalyzer with Arsenozo III and 
reagent (Parsazmun Company, Iran), was 
used to measure Ca; Mean intra- and 
interassay CVs were ≤1.7 and 2.0, 
respectively.  
A Hitachi 917 autoanalyzer with UV/VIS 
Photometric test and reagent (Parsazmun 
Company), was used to measure P; intra- 
and inter-assay coefficients of variation 
(CVs) were ≤1.6 and ≤2.2, respectively. A 
Hitachi 917 autoanalyzer with DGKC and 
reagent (Parsazmun Company), was used 
to measure ALP; Mean intra and inter 
assay CVs were <1.5 and <1.6, 
respectively. PTH was measured using 
Electrochemiluminescene (ECL) (Roche, 
Germany). Intra and inter assay 
coefficients of variation (CVs) were ≤ 2.7 
and ≤6.5, respectively. 25 (OH) D3 was 
measured using ELISA 
(Euroimmune, Germany). Intra and inter 
assay CVs were 4.4 and <8.2, respectively.  
2-5. Ethical consideration 
The ethics committee of Qazvin University 
of Medical Sciences approved the study 
protocol. Written informed consent was 
obtained from both parents and 
participants. 
2-6. Inclusion and exclusion criteria 
Inclusion criterion was diagnosis of Vit D 
deficiency or insufficiency without 
underlying disease. Children with chronic 
liver and renal diseases, hypothyroidism, 
cancer, malabsorption and those who were 
under corticosteroid therapy, treatment 
with antiepileptic drugs or multi-vitamins 
were excluded from the study.  
2-7. Data Analyses  
Data were described as mean ± standard 
deviation (SD) or number (percent) where 
appropriate. Categorical variables were 
analyzed by Chi square test. T-test was 
used for analysis of quantitative variables. 
P-values less than 0.05 were considered as 
statistically significant. All of the analyses 
were performed using the SPSS software, 
version 19.0 software. 
3- RESULTS 
    Totally, 207 children with 
hypovitaminose D were enrolled in the 
study. In the normal weight and obese 
groups, 37.6% and 40.6% of the 
participants were male, respectively (P: 
0.396). All subjects in the obese group 
completed the study. Five subjects (3.62 
%) in the normal weight group were lost to 
follow up due to long delay for visit after 
treatment. Demographic and biochemical 
characteristics of the participants at 
baseline are shown in Table.1.  
There was a significant difference 
regarding the mean BMI between the 
groups (P=0.001). Mean PTH (P= 0.009) 
and ALP (P= 0.017) levels in the obese 
group were significantly higher than the 
normal weight group. Biochemical 
characteristics of the participants after the 
follow up period are shown in Table.2.  
After three month, the mean 25 (OH) D3 
level in the normal weight and obese 
groups was increased; while PTH (P= 
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0.006) and ALP (P <0.001) levels were 
decreased but their difference was still 
statistically significant between the two 
groups. The Vit D status in both groups at 
baseline and after the follow up period has 
been shown in Table.3.  
39.8% of normal weight group still had Vit 
D insufficiency, while 50.7% of obese 
group had Vit D insufficiency or 
deficiency. Response to the treatment was 
better in normal weight group compared to 
the obese group with borderline 
significance. After follow up period in 
normal weight group, out of 92 subjects 
with Vit D insufficiency, 21.7% had still 
Vit D insufficiency and out of 41 
participants with Vit D deficiency, only 
19.5% were found normal, but all of them 
responded to the treatment. In the obese 
group, out of 42 participants with 
insufficiency, 26.2% did not respond to the 
treatment and out of 27 participants with 
Vit D deficiency, 11.1% were found 
normal and 7.4% did not respond to the 
treatment.  
The mean Vit D level at baseline was 15.9 
and 13 ng/mL in males and females, 
respectively. After the follow up period, 
the mean Vit D levels was 33.5 and 30.8 
ng/mL in males and females, respectively 
and also, the difference was not 
significant.  
 
Table-1: Demographic and biochemical characteristics of the study subjects at baseline   
Variable Normal weight Obese P-value 
Age (year) 9.7±2.8 9.3±2.3 0.257 
Body Mass Index (Kg/m2) 16.3±1.9 25.7±3.4 0.001 
Serum Calcium (mg/dL) 9.5±0.5 9.6±0.5 0.175 
Serum Phosphorus (mg/dL) 4.9±0.6 5±0.6 0.205 
ALP (IU/L) 623.1±199.1 683.5±151.6 0.017 
PTH (pg/mL) 34.3±13.5 39.9±15.5 0.009 
25 (OH) D (ng/ml) 14.5±7.2 13.5±7.2 0.369 
TSH (IU/dL) 2.7±1.4 3±1.4 0.298 
T4 (nmol/dL) 107±21.7 109.9±23.3 0.373 
Data are presented as mean± standard deviation (SD). 
Table-2: Biochemical characteristics of the study subjects three months after conventional Vit D 
therapy  
Variable Normal weight Obese P-value 
Serum Calcium (mg/dL) 9.5±0.48 9.6±0.46 0.176 
Serum Phosphorus (mg/dL) 4.8±0.5 4.9±0.5 0.397 
ALP (IU/L) 527.1±142.8 660.2±127.7 <0.001 
PTH (pg/mL) 32.9±12.2 38.2±13.3 0.006 
25 (OH) D (ng/ml) 33.0±8.5 29.6±8.6 0.007 
Data are presented as mean± standard deviation (SD). 
Saffari et al. 
Int J Pediatr, Vol.5, N.9, Serial No.45, Sep. 2017                                                                                             5729 
Table-3: Vitamin D status of the study subjects at baseline and three months after conventional Vit D 
therapy  
Group 
Vitamin D status 
P-value* At baseline Three months after conventional treatment 
Insufficiency Deficiency Normal Insufficiency Deficiency 
Normal weight 92 (69.2) 41 (30.8) 80 (60.2) 53 (39.8) 0 
0.064 
Obese 42 (60.9) 27 (39.1) 34 (49.3) 33 (47.8) 2 (2.9) 
Data are presented as number (percent); * Comparing Vitamin D status after conventional Vit D therapy 
between obese and non-obese children and adolescents by Chi-square test. 
 
4- DISCUSSION 
   There was an insignificant difference 
regarding the levels of Ca and P between 
the obese and normal weight children in 
the present study which was compatible 
with the results reported by some other 
studies. Rajakumar et al., found no 
significant difference between the levels of 
Ca and P in the obese and non-obese 
children with Vit D deficiency (22). Also, 
Arunabh et al., studied 410 healthy 
females with the age range of 20-80 years 
and reported no significant difference 
regarding the levels of Ca and P between 
the obese and non-obese cases; results of 
their study is consistent with those of the 
current study (14).  
The compensatory increase of PTH in 
blood, responding to the hypovitaminose 
D, preserves the level of blood Ca, even in 
the patients with prolonged Vit D 
deficiency and rickets. The hypocalcemia 
occurs only in severe conditions. The 
means PTH level was significantly 
different between the two groups in the 
present study; while in the study by 
Rajakumar et al., the PTH level in the 
obese and non-obese subjects with Vit D 
deficiency was statistically insignificant 
(22). According to the study by 
Alamzadeh et al., in the USA, people with 
Vit D deficiency had higher weights and 
higher PTH level (16). Parikh et al., 
obtained similar results about the level of 
PTH in adolescents; accordingly, in such 
patients the level of Vit D and PTH were 
higher and lower than those of non-obese 
ones, respectively (15). But these two 
mentioned studies did not compare the 
level of PTH in the obese and non-obese 
subjects with the same Vit D level. PTH is 
one of the functional indices of Vit D. 
Higher levels of PTH in the obese subjects 
is associated with decreased function of 
Vit D compared with non-obese subjects 
with the same Vit D level. In the present 
study, the mean ALP in the children with 
obesity was higher than normal weight 
children. It has been reported that the ALP 
level has direct relationship with obesity. 
In Conroy et al.'s study in obese children, 
the mean ALP reduced about 10% after 
treatment with leptin for weight loss, 
compared to that of the control group (23). 
In the present study, the mean 25 (OH) D3 
was significantly higher in the normal 
weight group, compared to the obese 
group, after the follow up period. Also, the 
response rate to conventional Vit D 
therapy in the normal weight group was 
higher than the obese group. Various 
studies compared the response to Vit D 
therapy in the obese and non-obese 
patients with Vit D deficiency. In the study 
by Rajkumar et al., 21 obese and 20 non-
obese children were compared before and 
after the treatment with Vit D (22); there 
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was no significant difference regarding the 
response to treatment between the obese 
and non-obese subjects (22) which is 
incompatible with the results of the present 
study. The difference in the type of 
treatment may be considered as one of the 
reasons for such incompatibility. The 
treatment in the mentioned study was the 
oral drops of Vit D (400 U/day), for one 
month and in the present study an 
intramuscular injections of Vit D 
(300,000-600000 IU) was applied. The 
ethnic differences between the participants 
of the studies and the few number of 
studies conducted on this topic also lead to 
find different results.  
On the other hand, in the study by 
Rajakumar et al., some differences were 
found between the obese and non-obese 
groups. These differences were at the 
threshold level of responding to treatment 
between the groups. In the obese and non-
obese groups, the responding thresholds 
were lower than 20 and 30ng/mL, 
respectively (22). No similar differences 
were observed between the groups of the 
present study. It should be considered that 
in the Rajakumar et al. study the cut point 
for Vit D insufficiency and deficiency 
were 20 and 30ng/mL, respectively; while 
these cut points were 10 and 30ng/mL in 
the present study. 
In the present study, the mean Vit D level 
in males was higher than females at 
baseline, which can be associated with the 
higher levels of fat mass in the females and 
more importantly, differences in females 
clothing and less exposure to sunlight in 
the countries like Iran, that is because of 
cultural and religious believes. After 
completing the treatment, the mean Vit D 
level was higher in males than females, but 
the difference was statistically 
insignificant. On the other hand, there was 
no difference regarding the response to 
treatment between the groups; while the 
Vit D level was lower in females than 
males, at baseline and after the follow up 
period. Season of Vit D sampling, physical 
activity and sun exposure of children are 
the important points in Vit D evaluation. In 
a study among 477 children and 
adolescents aged 9-18 years in Fars 
province- Iran during 2011, Vit D level 
had negative and significant correlation 
with BMI, pubertal status, and fat mass 
index; but it had positive and significant 
correlation with sun exposure (24).  
In addition, age, sun exposure, physical 
activity, pubertal status, and fat mass index 
were independent predictors of Vit D 
concentration in Saki et al. study (24). In 
another study, total fat percent and fat 
mass index had a negative correlation with 
serum concentration of 25(OH) D3 in 8–18 
years old patients with type 1 diabetes in 
Iran (25). In the present study, the 
participants were selected from similar 
location, family status, and residence to 
match their conditions; so sun exposure, 
dairy intake, and physical activity were not 
evaluated.  
4-1. Limitations of the study 
The present study had some limitations. 
Sun exposure, dairy intake, and physical 
activity were not evaluated. More 
longitudinal studies with larger sample 
size and longer follow up period are 
necessary to determine the differences in 
response to vitamin D therapy in obese and 
normal weight children and adolescents 
5- CONCLUSION 
   Therapeutic response to conventional Vit 
D therapy in obese children was less than 
normal weight children. It seems that 
treatment with higher doses of Vit D or 
longer period is necessary in obese 
children of the present study. Bone 
turnover markers (PTH and ALP level) in 
the obese children and adolescents were 
significantly higher than normal weight 
children and adolescents even with the 
same level of Vit D. 
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